Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patients

Fig. 2

Distribution of global longitudinal strain (GLS) at baseline, 1st month, at end of treatment and at 6th month of follow-up after treatment in the two groups of patients by treatment length, either 3 months (group A) or 6 months (group B). At each time point, the number of patient who performed cardiac ultrasound is showed below the X-axis

Back to article page